dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | González-Martínez, Silvia |
dc.contributor.author | Pérez-Mies, Belén |
dc.contributor.author | Carretero-Barrio, Irene |
dc.contributor.author | Palacios-Berraquero, María Luisa |
dc.contributor.author | Perez-Garcia, Jose Manuel |
dc.contributor.author | Cortés Castan, Javier |
dc.date.accessioned | 2021-08-26T10:20:16Z |
dc.date.available | 2021-08-26T10:20:16Z |
dc.date.issued | 2020-07-08 |
dc.identifier.citation | González-Martínez S, Pérez-Mies B, Carretero-Barrio I, Palacios-Berraquero ML, Perez-García J, Cortés J, et al. Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma. Cancers (Basel). 2020 Jul 8;12(7):1832. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/6239 |
dc.description | Carcinoma de mama metaplàsic; Alteracions moleculars; Pronòstic |
dc.description.sponsorship | This review was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI19/01331) and CIBERONC (CB16/12/00316 and CB16/12/00449), co-financed by the European Development Regional Fund. ‘A way to achieve Europe’ (FEDER), and by the Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;12(7) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Resistència als medicaments |
dc.subject.mesh | Triple Negative Breast Neoplasms |
dc.subject.mesh | Carcinoma, Squamous Cell |
dc.title | Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers12071832 |
dc.subject.decs | neoplasias de mama triple negativos |
dc.subject.decs | carcinoma de células escamosas |
dc.relation.publishversion | https://www.mdpi.com/2072-6694/12/7/1832 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [González-Martínez S] Clinical Researcher, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Pérez-Mies B] Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. Instituto Ramón y Cajal for Health Research (IRYCIS), Madrid, Spain. CIBER-ONC, Instituto de Salud Carlos III, Madrid, Spain. Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, Madrid, Spain. Breast Pathology Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Carretero-Barrio I] Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Palacios-Berraquero ML] Hematology and Hemotherapy Department, Clínica Universidad de Navarra, Pamplona, Spain. [Perez-García J] IOB Institute of Oncology, Quironsalud Group, Hospital Quiron, Barcelona, Spain. [Cortés J] CIBER-ONC, Instituto de Salud Carlos III, Madrid, Spain. IOB Institute of Oncology, Quironsalud Group, Hospital Quiron, Barcelona, Spain. IOB Institute of Oncology, Quironsalud Group, Madrid, Spain. Medica Scientia Innovation Research, 08018 Barcelona, Spain. Medica Scientia Innovation Research, Ridgewood, USA. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 32650408 |
dc.identifier.wos | 000558069400001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01331 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00316 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00449 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |